DE3325144C2 - Vernetztes Poly-beta-alanin und dieses enthaltende Mittel - Google Patents

Vernetztes Poly-beta-alanin und dieses enthaltende Mittel

Info

Publication number
DE3325144C2
DE3325144C2 DE3325144A DE3325144A DE3325144C2 DE 3325144 C2 DE3325144 C2 DE 3325144C2 DE 3325144 A DE3325144 A DE 3325144A DE 3325144 A DE3325144 A DE 3325144A DE 3325144 C2 DE3325144 C2 DE 3325144C2
Authority
DE
Germany
Prior art keywords
alanine
poly
crosslinked poly
indicates
crosslinked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3325144A
Other languages
German (de)
English (en)
Other versions
DE3325144A1 (de
Inventor
Claude Mahieu
Christos Papantoniou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19729921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3325144(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE3325144A1 publication Critical patent/DE3325144A1/de
Application granted granted Critical
Publication of DE3325144C2 publication Critical patent/DE3325144C2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/46—Post-polymerisation treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • C08G69/50—Polymers modified by chemical after-treatment with aldehydes
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3325144A 1982-07-13 1983-07-12 Vernetztes Poly-beta-alanin und dieses enthaltende Mittel Expired - Fee Related DE3325144C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU84268A LU84268A1 (fr) 1982-07-13 1982-07-13 Poly beta-alanine reticulee et ses differentes applications

Publications (2)

Publication Number Publication Date
DE3325144A1 DE3325144A1 (de) 1984-01-19
DE3325144C2 true DE3325144C2 (de) 1995-12-14

Family

ID=19729921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3325144A Expired - Fee Related DE3325144C2 (de) 1982-07-13 1983-07-12 Vernetztes Poly-beta-alanin und dieses enthaltende Mittel

Country Status (12)

Country Link
US (1) US4734286A (OSRAM)
JP (2) JPS5924723A (OSRAM)
AT (1) AT384616B (OSRAM)
BE (1) BE897262A (OSRAM)
CA (1) CA1212497A (OSRAM)
CH (1) CH660371A5 (OSRAM)
DE (1) DE3325144C2 (OSRAM)
FR (1) FR2530250B1 (OSRAM)
GB (1) GB2124638B (OSRAM)
IT (1) IT1163762B (OSRAM)
LU (1) LU84268A1 (OSRAM)
NL (1) NL188223C (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558171B1 (fr) * 1984-01-12 1986-08-01 Oreal Materiau polymerique a action enzymatique, son procede de preparation et son utilisation en tant que medicament
FR2582217B1 (fr) * 1985-05-22 1988-07-01 Oreal Compositions cosmetiques pour le traitement des cheveux et du cuir chevelu, contenant, en association, un polyamide hydrosoluble du type poly-beta-alanine et l'acide nicotinique ou l'un de ses esters, et leur utilisation
US5955109A (en) * 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
FR2624866B1 (fr) * 1987-12-16 1991-11-29 Oreal Procede de preparation de poly Ÿi2Ÿb-alanine reticulee sous forme de microspheres
FR2630326B1 (fr) * 1988-04-25 1990-08-03 Oreal Composition cosmetique pour le maquillage contenant des microspheres de poly (beta)-alanine reticulee impregnees d'un alcool polyhydrique inferieur
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
FR2648465B1 (fr) * 1989-06-15 1991-09-13 Oreal Procede de preparation de poly (beta)-alanine reticulee, en une seule etape, a partir d'acrylamide et d'un compose polyfonctionnel copolymerisable
FR2653339B1 (fr) * 1989-10-24 1991-12-27 Oreal Compositions cosmetique et pharmaceutique contenant des spheres de poly beta-alanine reticulee impregnees d'une substance lipophile.
FR2675377B1 (fr) * 1991-04-22 1995-02-03 Oreal Microspheres poreuses enrobees a l'aide d'une huile perfluoree, d'une huile de silicone fluoree ou d'une gomme de silicone et leur utilisation en cosmetique.
JP3545429B2 (ja) * 1992-07-13 2004-07-21 株式会社資生堂 レチノール安定配合皮膚外用剤
FR2762504B1 (fr) 1997-04-29 1999-09-10 Cird Galderma Procede d'epilation
DE10029596A1 (de) * 2000-06-15 2002-01-24 Degussa Polybetaaminosäuren als Epoxidierungs-Katalysatoren
JP2012015210A (ja) * 2010-06-29 2012-01-19 Japan Ae Power Systems Corp 分解輸送変圧器鉄心

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE462554A (OSRAM) * 1941-11-27
US2858259A (en) * 1952-12-06 1958-10-28 Gen Electric Electron irradiation of preformed polyamide resin
US2967137A (en) * 1956-11-21 1961-01-03 Gen Electric Irradiation of nylon
US3098806A (en) * 1959-12-10 1963-07-23 Gen Mills Inc Cross linking of fatty polyamides with ionizing radiation
US3607622A (en) * 1968-07-24 1971-09-21 Hercules Inc Aminopolyamide-acrylamide-polyaldehyde resins having utility as wet and dry strength agents, retention aids and flocculants and a process of making and using them and paper made therefrom
US3728214A (en) * 1971-03-12 1973-04-17 Hercules Inc Polyamine-acrylamide-polyaldehyde resins having utility as wet and dry strengthening agents in papermaking
US3728215A (en) * 1971-03-12 1973-04-17 Hercules Inc Aminopalyamide{13 acrylamide{13 polyaldehyde resins employing an alpha, beta-unsaturated monobasic carboxylic acid or ester to make the aminopolyamide and their utility as wet and dry strengthening agents in papermaking
US4079044A (en) * 1974-11-04 1978-03-14 Hercules Incorporated Glyoxal modified poly(β-alanine) strengthening resins for use in paper
US4035229A (en) * 1974-11-04 1977-07-12 Hercules Incorporated Paper strengthened with glyoxal modified poly(β-alanine) resins
US4060507A (en) * 1975-08-01 1977-11-29 General Mills Chemicals, Inc. Aminopolyamide-acrylamide-glyoxal resin
US4187852A (en) * 1976-07-09 1980-02-12 The University Of Alabama Synthetic elastomeric insoluble cross-linked polypentapeptide
DE2713198A1 (de) * 1977-03-25 1978-10-05 Bayer Ag Stabile polymergele

Also Published As

Publication number Publication date
NL188223B (nl) 1991-12-02
JPH0525863B2 (OSRAM) 1993-04-14
DE3325144A1 (de) 1984-01-19
GB2124638A (en) 1984-02-22
AT384616B (de) 1987-12-10
BE897262A (fr) 1984-01-12
GB2124638B (en) 1985-09-18
IT1163762B (it) 1987-04-08
CH660371A5 (fr) 1987-04-15
US4734286A (en) 1988-03-29
CA1212497A (fr) 1986-10-07
ATA254583A (de) 1987-05-15
LU84268A1 (fr) 1984-03-22
NL188223C (nl) 1992-05-06
GB8318819D0 (en) 1983-08-10
NL8302492A (nl) 1984-02-01
FR2530250B1 (fr) 1985-06-21
JPS5924723A (ja) 1984-02-08
FR2530250A1 (fr) 1984-01-20
JPH0357933B2 (OSRAM) 1991-09-03
IT8322025A0 (it) 1983-07-12
JPH03173831A (ja) 1991-07-29

Similar Documents

Publication Publication Date Title
DE69114006T2 (de) Zusammensetzungen und verfahren für die kontrollierte freisetzung von löslichen wirkstoffen.
DE60202662T2 (de) NEUE FILMBESCHICHTUNG enthaltend ein Äthylacrylate/Methylmethacrylate-copolymer und Polyvinylacetat
DE1949894C3 (de) Feste oder gelformige Arzneiform mit verzögerter Wirkstoff Freigabe
EP0181515B1 (de) Verfahren zur Herstellung einer wässrigen Überzugsmitteldispersion und ihre Verwendung zum Überziehen von Arzneimitteln
DE3786316T2 (de) Überzugsmembran und damit hergestellte Mittel.
DE3106984C2 (de) Verfahren zur Herstellung eines mehrschichtigen Verbundstoffs mit Langzeit-Freigabe
DE69014081T2 (de) Mittel zur Feuchthaltung vaginalen Gewebes.
DE69419447T2 (de) Salbe zur Wundbehandlung
EP0086997B1 (de) Verfahren zur Herstellung einer pharmazeutischen Zubereitung in Form eines Polyacrylat-Films
DE69713367T2 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit veränderter wirkstoffsfreisetzung, enthaltend eine matrix
CH672598A5 (OSRAM)
DE2721603C3 (de) Beschichtete Körnchen aus Alkalimetallsalzen der Polyacrylsäure und Verfahren zu ihrer Herstellung
DD201754A5 (de) Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung
EP0164669A2 (de) Verfahren zum Überziehen von Arzneiformen
WO1998014199A1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
DE69813872T2 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
DE1467781A1 (de) Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
DE3325144A1 (de) Vernetztes poly-(beta)-alanin und dessen verwendung
DE60126332T2 (de) Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin
EP0100458B1 (de) Mittel zur Behandlung von Wunden
DE69609501T2 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
DE69026312T2 (de) Verfahren zur Herstellung von vernetztem Polybeta-alanin in einem einzigen Schritt aus Acrylamid und einer polyfunktionalen copolymerisierbaren Verbindung
DE69008117T2 (de) Endermaler Arzneistoff in einer Gelbasis.
DE60030319T2 (de) Gelzubereitung enthaltend einen gelösten oder suspendierten wirkstoff,insbesondere zur anwendung auf einer schleimhaut und herstellungsverfahren
CH642259A5 (de) Galenische zubereitungen fuer orale applikation von ergotalkaloiden.

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C08G 69/46

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee